MedPath

Beclanorsen

Generic Name
Beclanorsen
Drug Type
Small Molecule
CAS Number
1072859-54-1
Unique Ingredient Identifier
ZV9069GJO5

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in leukemia (lymphoid).

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Completed
Posted: 2006/02/01
Sponsor:
Santaris Pharma A/S

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath